Effect of octreotide on refractory AIDS-associated diarrhea: a prospective, multicenter clinical trial
JP Cello, JH Grendell, P Basuk, D Simon… - Annals of internal …, 1991 - acpjournals.org
▪ Objective: To determine the efficacy and safety of octreotide for treatment of refractory,
profuse diarrhea in patients with the acquired immunodeficiency syndrome (AIDS).▪ Design:
A prospective, open-label study.▪ Setting: Inpatient metabolic units of four university medical
centers.▪ Patients: Fifty-one patients infected with human immunodeficiency virus (HIV) who
had uncontrolled diarrhea (≥ 500-mL liquid stool per day) despite treatment with maximally
tolerable doses of antidiarrheal medications.▪ Intervention: After initial baseline studies …
profuse diarrhea in patients with the acquired immunodeficiency syndrome (AIDS).▪ Design:
A prospective, open-label study.▪ Setting: Inpatient metabolic units of four university medical
centers.▪ Patients: Fifty-one patients infected with human immunodeficiency virus (HIV) who
had uncontrolled diarrhea (≥ 500-mL liquid stool per day) despite treatment with maximally
tolerable doses of antidiarrheal medications.▪ Intervention: After initial baseline studies …
[引用][C] Effect of octreotide on refractory AIDS-associated diarrhea
C Jp - Ann. Intern. Med., 1991 - cir.nii.ac.jp
Effect of octreotide on refractory AIDS-associated diarrhea | CiNii Research … Effect of
octreotide on refractory AIDS-associated diarrhea …
octreotide on refractory AIDS-associated diarrhea …